Interleukin-I cluster combined genotype and restenosis after balloon angioplasty

Thrombosis and Haemostasis

Volumn 90, Issue 3, 2003, Pages 491-500

  Marculescu, Rodrig ^a   Mlekusch, Wolfgang ^a   Exner, Markus ^a   Sabeti, Schila ^a   Michor, Stefanie ^a   Rumpold, Helmut ^a   Mannhalter, Christine ^a   Minar, Erich ^a   Wagner, Oswald ^a   Schillinger, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Cytokines; Gene mutations; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; SERUM AMYLOID A; IL1RN PROTEIN, HUMAN; SIALOGLYCOPROTEIN;

AGED; ALLELE; ARTICLE; CLINICAL TRIAL; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GENE; GENE DOSAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFLAMMATION; INTRON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VARIABLE NUMBER OF TANDEM REPEAT; VASCULAR DISEASE; ARTERIOSCLEROSIS; GENE LINKAGE DISEQUILIBRIUM; GENETICS; MULTIGENE FAMILY; MUTATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; GENE DOSAGE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; MALE; MULTIGENE FAMILY; MUTATION; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS;

EID: 0141651859     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-01-0064     Document Type: Article

References (45)

1. Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation. J Endovasc Ther 2001; 8(5): 477-83.
2. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: Association with restenosis. Radiology 2002; 225(1): 21-6.
3. Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 2000; 86(4B):6H-11H.
4. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340(2): 115-26.
5. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98(22): 2370-6.
6. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21(14): 1152-8.
7. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999; 10(6): 499-506.
8. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99(1): 44-52.
9. Ikeda U, Ikeda M, Oohara T, et al. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 1990; 84(2-3): 183-8.
10. Ikeda U, Ikeda M, Oohara T, et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991; 260(5 Pt 2): H1713-H1717.
11. Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 1987; 166(1): 235-45.
12. Fukumoto Y, Shimokawa H, Ito A, et al. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. J Cardiovasc Pharmacol 1997; 29(2): 222-31.
13. Feldman LJ, Aguirre L, Ziol M, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000; 101(8): 908-16.
14. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther 2002; 9(1): 59-66.
15. Schillinger M, Exner M, Mlekusch W, et al. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries. Thromb Haemost 2002; 87(6): 959-65.
16. Schillinger M, Exner M, Mlekusch W, et al. Immediate and 6 months results after endovascular revascularisation below the knee: Predictive value of C-reactive protein. Radiology 2003. In press.
17. Schillinger M, Exner M, Mlekusch W, et al. Restenosis after femoropopliteal PTA and Elective Stent Implantation: Potential Role of Monocyte Counts. J Endovasc Ther. In press.
18. Schillinger M, Exner M, Mlekusch W, et al. Acute phase response after carotid stenting: Association with 6 months instent restenosis. Radiology 2003. In press.
19. Danenberg HD, Welt FG, Walker M, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 2002; 105(24): 2917-22.
20. Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36(7): 2168-73.
21. Wang X, Romanic AM, Yue TL, et al. Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem Biophys Res Commun 2000; 271(1): 138-43.
22. Francis SE, Camp NJ, Dewberry RM, et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99(7): 861-6.
23. Francis SE, Camp NJ, Burton AJ, et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001; 86(3): 336-40.
24. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001; 38(3): 712-7.
25. Marculescu R, Endler G, Schillinger M, et al. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 2002; 51(12): 3582-5.
26. Cox A, Camp NJ, Nicklin MJ, et al. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998; 62(5): 1180-8.
27. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: Correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992; 18(5): 433-40.
28. Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection. Nucleic Acids Res 1993; 21(16): 3623-9.
29. Terwilliger J, Ott J. Handbook of Human Genetic Linkage. Johns Hopkins University Press, Baltimore, 1994.
30. Weir BS. Inferences about linkage disequilibrium. Biometrics 1979; 35(1): 235-54.
31. Garnier-Gere P, Dillmann C. A computer program for testing pairwise linkage disequilibria in subdivided populations. J Hered 1992; 83(3): 239.
32. Schneider S, Roessli D, Excoffier L. Arlequin: A Software for Population Genetics Data Analysis. Ver 2.000. Genetics and Biometry Lab, Dept of Anthropology, University of Geneva 2002.
33. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50(2): 133-9.
34. El Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404(6776): 398-402.
35. Kastrati A, Dirschinger J, Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000; 25(1): 34-46.
36. Bauters C, Lamblin N, Amouyel P. Gene polymorphisms and outcome after coronary angioplasty. Curr Interv Cardiol Rep 2001; 3(4): 281-6.
37. Roguin A, Hochberg I, Nikolsky E, et al. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 2001; 87(3): 330-2, A9
38. Jukema JW, Kastelein JJ. Tailored therapy to fit individual profiles. Genetics and coronary artery disease. Ann N Y Acad Sci 2000; 902: 17-24; discussion 24-6.: 17-24.
39. Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001; 8(5): 433-40.
40. Roubenoff R, Harris TB, Abad LW, et al. Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998; 53(1): M20-M26.
41. Zee RY, Lunze K, Lindpaintner K, Ridker PM. A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 2001; 86(5): 1141-3.
42. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998; 28(8): 2598-2602.
43. Wang X, Romanic AM, Yue TL, et al. Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem Biophys Res Commun 2000; 271(1): 138-43.
44. Libby P, Schwartz D, Brogi E, et al. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992; 86(6 Suppl): III47-III52.
45. Jiang SL, Lozanski G, Samols D, Kushner I. Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. J Immunol 1995; 154(2): 825-31.